Tumor-specific CD4+ T cells have been shown to promote CXCL9/10 expression through IFN-γ–dependent mechanisms that increase CD8+ T cell recruitment, particularly of low-affinity T cell receptor (TCR) CD8+ T cell clones (20, 21). The gene discussed is IFNG; the disease is neoplasm.